| Serial Number | 90894329 |
| Word Mark | ENTOS |
| Filing Date | Friday, August 20, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 29, 2023 |
| Registration Number | 7151783 |
| Registration Date | Tuesday, August 29, 2023 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 25, 2022 |
| Translation of Words in Mark | The English translation of ENTOS in the mark is WITHIN. |
| Goods and Services | research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 7, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, October 3, 2013 |
| First Use In Commerce Date | Thursday, October 3, 2013 |
| Party Name | ENTOS PHARMACEUTICALS INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | EDMONTON, AB T5J4P6 CA |
| Party Name | Entos, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90027 |
| Party Name | Entos, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90027 |
| Party Name | Entos, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90027 |
| Event Date | Event Description |
| Tuesday, August 24, 2021 | NEW APPLICATION ENTERED |
| Wednesday, September 8, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, September 8, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 8, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, October 7, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 23, 2022 | ASSIGNED TO EXAMINER |
| Monday, May 23, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, May 23, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, May 23, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, September 16, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 16, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, September 17, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 20, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 5, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 25, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 25, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, October 27, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Thursday, May 4, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, June 13, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, June 30, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Friday, June 30, 2023 | USE AMENDMENT FILED |
| Monday, July 24, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 25, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, July 26, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, July 27, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, August 29, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 29, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 30, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, September 1, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, September 1, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 1, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 1, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, September 1, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, September 1, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, September 1, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Saturday, January 4, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Saturday, January 4, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, January 4, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Saturday, January 4, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, January 4, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Saturday, January 4, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |